Bioengineering efficient antibiotic biosynthesis in E. coli

Feb 06, 2007

The pathways underlying the production of antibiotics are now quite well known. For example, the antibacterial activity of erythromycin, an important polyketide antibiotic precursor, requires the transfer of two unusual sugars called mycarose and desosamine (both glycosyl groups) onto the nonsugar part of the glycoside molecule (macrocyclic aglycone).

In a new study published online this week in the open-access journal PLoS Biology, Ho Young Lee and Chaitan Khosla demonstrate how they used bioassay-guided evolution of this antibiotic pathway in Escherichia coli (E. coli) to identify more efficient antibiotic-producing mutants.

The authors reconstituted the biosynthetic pathways of both sugars in E. coli to yield the 6-deoxyerythromycin D antibiotic. By engineering a recombinant strain of E. coli that produces the bioactive macrolide 6-deoxyerythromycin D from propionate, they developed a fundamentally new tool for enhancing the efficiency of biosynthetic engineering of this class of antibiotics. Initially, this recombinant strain produced barely enough antibiotic activity to establish an activity-based screening assay.

The authors therefore used the assay to screen for antibiotic overproducers. After three rounds of screening, they were able to identify E. coli cells that overproduced the 6-deoxyerythromycin D antibiotic with significant modifications in the mycarose biosynthetic pathway. They used the same activity-based screening system to evolve E. coli mutants capable of more efficient precursor-directed biosynthesis. As the first example of bioassay-guided evolution of an antibiotic pathway in E. coli, these results open the door for harnessing the power of genetics for mechanistic investigations into polyketide synthases and also for biosynthetic engineering.

Source: Public Library of Science

Explore further: Geneticists solve 40-year-old dilemma to explain why duplicate genes remain in the genome

add to favorites email to friend print save as pdf

Related Stories

Erythromycin A produced in E. coli for first time

Nov 24, 2010

(PhysOrg.com) -- Researchers at Tufts University School of Engineering have reported the first successful production of the antibiotic erythromycin A, and two variations, using E. coli as the production host. ...

Scientists crack code of critical bacterial defense mechanism

Apr 25, 2010

Scientists have combined chemistry and biology research techniques to explain how certain bacteria grow structures on their surfaces that allow them to simultaneously cause illness and protect themselves from the body's defenses.

Researchers eliminate drug discovery bottleneck

Mar 31, 2008

Determining the structure of unknown natural compounds is a slow and expensive part of drug screening and development – but this may now change thanks to a new combination of experimental and computational ...

Cloning techniques produce FDA-approved antibiotic

Nov 27, 2006

The successful synthesis of an antibiotic in a non-native host has provided a team of researchers at the University of Illinois at Urbana-Champaign with the potential for developing new treatments for bacterial infections.

Recommended for you

World's first microbe 'zoo' opens in Amsterdam

4 hours ago

The world's first "interactive microbe zoo" opened in Amsterdam on Tuesday, shining new light on the tiny creatures that make up two-thirds of all living matter and are vital for our planet's future.

User comments : 0